Quantcast

Latest Schering-Plough Corporation Stories

2011-08-02 07:00:00

MIAMI, Aug. 2, 2011 /PRNewswire/ -- Femina Pharma Incorporated announced that Order No. 16 in Investigation No. 337-TA-768 (In the matter of Certain Vaginal Ring Birth Control Devices) was issued by the Chief Administrative Law Judge ("CALJ") at the United States International Trade Commission ("ITC") finding fourteen parties - thirteen Canadian Internet pharmacies and one U.S. Internet pharmacy -- in default. On February 11, 2011, Femina Pharma Incorporated filed a complaint with the...

2011-07-20 07:00:00

MIAMI, July 20, 2011/PRNewswire-USNewswire/ -- Femina Pharma Incorporated announced that Order No. 14 in Investigation No. 337-TA-768 (In the matter of Certain Vaginal Ring Birth Control Devices) was issued by the Chief Administrative Law Judge at the United States International Trade Commission ("ITC") denying Merck's Motion for Summary Determination of Invalidity of U.S. Patent No. 6,086,909. On February 11, 2011, Femina Pharma Incorporated filed a complaint with the ITC for...

2010-03-15 06:00:00

ROCHESTER, N.Y., March 15 /PRNewswire/ -- Bausch + Lomb has named Fred Hassan as chairman of the Board of Directors and has named Brent Saunders as chief executive officer and appointed him to the Board of Directors, effective immediately. Current Chairman and CEO Gerald M. Ostrov is retiring, and will serve as a consultant to the new leaders. Mr. Hassan is one of the leading figures in global healthcare. He served most recently as chairman and CEO of Schering-Plough Corporation until...

2009-11-02 16:30:00

BOSTON, Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1. In the lead-in arms of the study, in which patients received a 4-week lead-in of PEGINTRON(R) (peginterferon alfa-2b) and REBETOL(R) (ribavirin,...

2009-11-02 09:26:00

KENILWORTH, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through improved educational awareness and mass vaccination of dogs. The company will donate $200,000 and rabies vaccine from Intervet/Schering-Plough as well as share expertise with partners to support successful implementation of the projects in ten villages surrounding Bangalore...

2009-11-02 07:38:00

KENILWORTH, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy...

2009-11-01 16:00:00

BOSTON, Nov. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported two data presentations supporting response guided therapy with boceprevir combination therapy in patients with chronic hepatitis C virus (HCV) genotype 1. These retrospective analyses were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston, Oct. 30-Nov. 3. Boceprevir is an investigational HCV protease inhibitor. Phase III registration...

2009-10-22 05:30:00

KENILWORTH, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter. "This quarter we delivered operational top-line growth, reconciled bottom-line growth and major pipeline successes. We powered through - even in the face of tough global economic and currency headwinds," said Fred Hassan, chairman and CEO. "As we near the anticipated close of our combination with Merck, we are proud of how our...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related